Effect of Proton Pump Inhibitor of Daily Use for One Month on Kidney Function Test
NCT04022837 · Status: UNKNOWN · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 200
Last updated 2019-07-17
Summary
The aim of this study to:
evaluate the association between prolonged use of PPI and adverse renal outcomes on patients with normal renal function and others with abnormal renal function
Conditions
- Proton Pump Inhibitor Allergy
Interventions
- DRUG
-
Pantoprazole 40mg
effect of this drug on renal function
Sponsors & Collaborators
-
Assiut University
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- SCREENING
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Max Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2019-11-01
- Primary Completion
- 2020-11-30
- Completion
- 2021-12-31
More Related Trials
-
Should I Continue Taking My Acid Reflux Medication? Development and Pilot Testing of a Patient Decision Aid
NCT02558049 ·Status: COMPLETED ·Phase: NA
-
Efficacy of Proton Pump Inhibitor in Prevention of Clopidogrel-related Peptic Ulcer
NCT01138969 ·Status: COMPLETED ·Phase: PHASE2
-
Intravenous Proton Pump Inhibitor for Peptic Ulcer Bleeding
NCT00731601 ·Status: COMPLETED ·Phase: PHASE4
-
PPI Sequencing Study
NCT00384592 ·Status: COMPLETED ·Phase: PHASE4
-
To Learn How Bone Structure and Bone Mass Change After Long-term PPI Use
NCT01306799 ·Status: COMPLETED
-
Pilot Study To Investigate The Association Between Acid Control And Heartburn Symptoms After Proton Pump Inhibitor Treatment
NCT02708355 ·Status: COMPLETED ·Phase: PHASE4
-
Inappropriate Prescribing of Proton-pump Inhibitor is it Associated With the Burden of Comorbidities in Older Patients?
NCT02841852 ·Status: COMPLETED
-
The Clinical Significance of Acid Rebound in Functional Dyspepsia
NCT01373970 ·Status: TERMINATED ·Phase: PHASE4
-
Optimal Dose of Proton Pump Inhibitors Following an Upper Gastrointestinal Bleed
NCT02235311 ·Status: TERMINATED ·Phase: NA
-
A Study to Monitor Intragastric pH in Patients Taking Rabeprazole vs. Patients Taking Pantoprazole
NCT00378287 ·Status: COMPLETED ·Phase: PHASE1
-
Study of Long-Term Use of Proton-Pump-Inhibitors in General Practice
NCT00363701 ·Status: UNKNOWN ·Phase: PHASE4
-
Effect of Digene Total (Buffered Pantoprazole) on 24 Hour Gastric Potential Hydrogen (pH) in Patients From Acid Peptic Disorder After Single and Repeated Dosing.
NCT01214408 ·Status: COMPLETED ·Phase: PHASE4
-
Oral vs Intravenous and Proton Pump Inhibitor (PPI)for Peptic Ulcer Bleeding (PUB)
NCT01123031 ·Status: WITHDRAWN ·Phase: PHASE4
-
Evaluation of Rebound Effect After Withdrawal of Proton Pump Inhibitor in Geriatric Population
NCT03467893 ·Status: COMPLETED
-
Comparison of Early Proton Pump Inhibitor Initiation Versus Usual Care on Acute Kidney Injury in Hemorrhagic Shock Patients
NCT06531642 ·Status: RECRUITING ·Phase: PHASE2/PHASE3
-
AGN 201904 Versus Esomeprazole in the Prevention of Aspirin-induced Stomach or Upper Intestinal Damage in Healthy Volunteers
NCT00325715 ·Status: COMPLETED ·Phase: PHASE1
-
Efficacy of Low Dose of Proton Pump Inhibitor in Treatment Bleeding Ulcers
NCT03163680 ·Status: COMPLETED
-
ASP (PPI_H2RA) Study-H2RA Versus PPI for the Prevention of Recurrent UGIB in High-risk Users of Low-dose ASA
NCT01408186 ·Status: COMPLETED ·Phase: PHASE3
-
EffCaMgCit to Prevent Mineral Metabolism and Renal Complications of Chronic PPI Therapy
NCT05998863 ·Status: RECRUITING ·Phase: PHASE3
-
A Comparative Study of Proton-pump Inhibitor Tests for Chinese Reflux Patients in Relation to the CYP2C19 Genotypes
NCT00681005 ·Status: COMPLETED ·Phase: NA
-
The Utility of Nexium in Chronic Cough and Reflux Disease
NCT00287339 ·Status: COMPLETED ·Phase: PHASE4
-
PPI Infusion Versus Oral Acid Pump Inhibitors for Bleeding Peptic Ulcers
NCT05582174 ·Status: RECRUITING ·Phase: PHASE4
-
High Versus Standard Dose of Proton Pump Inhibitors (PPIs) in Peptic Ulcer Bleeding
NCT00374101 ·Status: COMPLETED ·Phase: PHASE3
-
The Effect of Dual Eradication Therapy vs PPI on Gastrointestinal Bleeding in ACS Patients
NCT04728516 ·Status: RECRUITING ·Phase: PHASE4
-
Proton Pump Inhibitor Versus Histamine-2 Receptor Antagonist for the Prevention of Recurrent Peptic Ulcers
NCT02551744 ·Status: COMPLETED ·Phase: NA